gadolinium enhancement on brain MRI
1 drugsPredictive biomarker for patient selection in 1 indication
1
Approved Drugs
1
Indications
1
Companies
gadolinium enhancement on brain MRI is a precision-medicine biomarker linked to 1 FDA-approved targeted drug from 1 company, spanning 1 indication including Cerebral Adrenoleukodystrophy. Explore the targeted therapies, indications, testing methods, and companies developing gadolinium enhancement on brain MRI drugs below.
Search gadolinium enhancement on brain MRI Clinical Trials
Search recruiting trials on ClinicalTrials.gov
Drugs Targeting gadolinium enhancement on brain MRI
| Drug | Company | Therapeutic Area |
|---|---|---|
| Skysona | bluebird bio |
gadolinium enhancement on brain MRI Indications
Cerebral Adrenoleukodystrophy